Home » Advanced Oncotherapy (AVO) » Advanced Oncotherapy (AVO) – Discussed by Mark Brewer – Hardman & Co Analyst
Mark Brewer – Hardman & Co Life Sciences Analyst discusses with DirectorsTalk Advanced Oncotherapy Plc, it’s unique technology, the market size, growth drivers, key risks and an outlook for the company.
Tags: advanced oncotherapy, avo, hardman & co, mark brewer, proton beam therapy
You must be logged in to post a comment.
Powered by WordPress / Academica WordPress Theme by WPZOOM